Abstract
Narrow-band ultraviolet B (NB-UVB) phototherapy is an effective and widely used treatment modality for psoriasis and other inflammatory skin diseases. The carcinogenic effect of PUVA treatment has been investigated extensively, but there is very scarce data about the role of NB-UVB in the development of skin cancer. The aim of this study was to investigate the potential carcinogenic risk of NB-UVB therapy in various skin disorders. In this cross-sectional study, we evaluated 100 patients who had received whole-body NB-UVB treatment and 100 age- and sex-matched controls. Phototherapy unit database was used to identify patients. A total of 100 patients (53 males and 47 females) treated with NB-UVB and 100 controls were included in the study. The patient group revealed no cases of melanoma or non-melanoma skin cancer, while ten of them were found to have solar lentigines. Basal cell carcinoma in a patient and nine patients with solar lentigines were detected in the control group. There was no statistically significant difference between patient and control groups in terms of skin cancer and solar lentigines. This study does not provide evidence for an increased skin cancer risk in patients treated with NB-UVB phototherapy. However, we have detected the occurence of 10 cases of solar lentigines. Still, definitive prospective longitudinal studies with a greater number of patients and prolonged follow-up are required to specifically address skin cancer risk in relation to NB-UVB phototherapy.
Similar content being viewed by others
References
Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maitre M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA (2012) Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 26(Suppl 3):22–31. https://doi.org/10.1111/j.1468-3083.2012.04520.x
Black RJ, Gavin AT (2006) Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data. Br J Dermatol 154:566–567. https://doi.org/10.1111/j.1365-2133.2005.07085.x
Chiesa Fuxench ZC, Shin DB, Ogdie Beatty A, Gelfand JM (2016) The risk of cancer in patients with psoriasis: a population-based cohort study in the health improvement network. JAMA Dermatol 152:282–290. https://doi.org/10.1001/jamadermatol.2015.4847
Dawe RS (2003) A quantitative review of studies comparing the efficacy of narrow-band and broad-band ultraviolet B for psoriasis. Br J Dermatol 149:669–672
Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ (1997) Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 337:1419–1428. https://doi.org/10.1056/NEJM199711133372003
Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW (2002) Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 47:191–197
Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS (2008) Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 159:931–935. https://doi.org/10.1111/j.1365-2133.2008.08776.x
Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T (2003) UV-induced skin damage. Toxicology 189:21–39
Kilinc Karaarslan I, Teban L, Dawid M, Tanew A, Kittler H (2007) Changes in the dermoscopic appearance of melanocytic naevi after photochemotherapy or narrow-band ultraviolet B phototherapy. J Eur Acad Dermatol Venereol 21:526–531. https://doi.org/10.1111/j.1468-3083.2006.02020.x
Kripke ML (1981) Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res 34:69–106
Kunisada M, Kumimoto H, Ishizaki K, Sakumi K, Nakabeppu Y, Nishigori C (2007) Narrow-band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer. J Invest Dermatol 127:2865–2871. https://doi.org/10.1038/sj.jid.5701001
Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ (2018) Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: results from a Taiwanese population-based cohort study. Photodermatol Photoimmunol Photomed. https://doi.org/10.1111/phpp.12443
Maiorino A, De Simone C, Perino F, Caldarola G, Peris K (2016) Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy. J Dermatol Treat 27:443–447. https://doi.org/10.3109/09546634.2015.1133882
Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J (2005) The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol 152:755–757. https://doi.org/10.1111/j.1365-2133.2005.06537.x
Manganoni AM, Rossi MT, Sala R, Venturini M, Sereni E, Ungari M, Marocolo D, Lonardi S, Calzavara-Pinton P (2012) Dermoscopic, histological and immunohistochemical evaluation of cancerous features in acquired melanocytic nevi that have been repeatedly exposed to UVA or UVB. Exp Dermatol 21:86–90. https://doi.org/10.1111/j.1600-0625.2011.01397.x
Nardone B, Hammel JA, Raisch DW, Weaver LL, Schneider D, West DP (2014) Melanoma associated with tumour necrosis factor-alpha inhibitors: a research on adverse drug events and reports (RADAR) project. Br J Dermatol 170:1170–1172. https://doi.org/10.1111/bjd.12779
Nijsten TE, Stern RS (2003) The increased risk of skin cancer is persistent after discontinuation of psoralen+ ultraviolet A: a cohort study. J Invest Dermatol 121:252–258. https://doi.org/10.1046/j.1523-1747.2003.12350.x
Pathak MA (1991) Ultraviolet radiation and the development of non-melanoma and melanoma skin cancer: clinical and experimental evidence. Skin Pharmacol 4(Suppl 1):85–94
Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, Lamarque V, Dubertret L (2003) Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 years cohort study. J Invest Dermatol 120:211–216. https://doi.org/10.1046/j.1523-1747.2003.12040.x
Scherschun L, Kim JJ, Lim HW (2001) Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 44:999–1003. https://doi.org/10.1067/mjd.2001.114752
Schulman JM, Fisher DE (2009) Indoor ultraviolet tanning and skin cancer: health risks and opportunities. Curr Opin Oncol 21:144–149. https://doi.org/10.1097/CCO.0b013e3283252fc5
Stern RS, Nichols KT, Vakeva LH (1997) Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med 336:1041–1045. https://doi.org/10.1056/NEJM199704103361501
Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB (1979) Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 300:809–813. https://doi.org/10.1056/NEJM197904123001501
van Lumig PP, Menting SP, van den Reek JM, Spuls PI, van Riel PL, van de Kerkhof PC, Fransen J, Kievit W, de Jong EM (2015) An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors. J Eur Acad Dermatol Venereol 29:752–760. https://doi.org/10.1111/jdv.12675
Van Weelden H, Baart de la Faille H, Young E, van der Leun JC (1990) Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol 70:212–215
van Weelden H, De La Faille HB, Young E, van der Leun JC (1988) A new development in UVB phototherapy of psoriasis. Br J Dermatol 119:11–19
Walker D, Jacobe H (2011) Phototherapy in the age of biologics. Semin Cutan Med Surg 30:190–198. https://doi.org/10.1016/j.sder.2011.08.004
Weischer M, Blum A, Eberhard F, Rocken M, Berneburg M (2004) No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol 84:370–374. https://doi.org/10.1080/00015550410026948
Wulf HC, Hansen AB, Bech-Thomsen N (1994) Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed 10:192–197
Zaher H, Bassiouny D, Abdel Hay R, Samir N, Ragab N, Sayed S (2016) Dermoscopic and immunohistochemical changes in acquired melanocytic nevi following narrow-band ultraviolet B therapy. Dermatology 232:273–278. https://doi.org/10.1159/000445780
Acknowledgements
The authors declare that there are no relationships that provided financial or editorial support for the study which may in potential cause competing interest for the submission.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by NK, EK, EKN, IGI, OK, ME and POC. The first draft of the manuscript was written by NK and POC and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Karaosmanoglu, N., Ozdemir Cetinkaya, P., Kutlu, O. et al. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients. Arch Dermatol Res 312, 249–253 (2020). https://doi.org/10.1007/s00403-019-02007-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-019-02007-7